ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Efficacy of transoral partial laryngectomy with zeitels and holmium laser in 42 glottic cancers.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo evaluate the efficacy of transoral partial laryngectomy using the suspension Zeitels laryngoscope system and holmium laser assistance (SZL-HoL) in the treatment of glottic laryngeal cancer.
methodsA retrospective analysis was conducted on 42 patients who underwent SZL-HoL and 43 patients who underwent Open Partial Laryngectomy (OPL) from January 2017 to January 2025. Patients had T1b-T2 and selected T3 glottic cancer. The study compared survival rates, intraoperative blood loss, tracheotomy rates and decannulation times, nasogastric tube placement rates and removal times, postoperative voice recovery, and hospital stay.
resultsPatients in the SZL-HoL group showed Table five-year overall survival compared with those in the OPL group (92.3% vs. 81.32%, P = 0.045), although disease-specific survival and local control did not reach statistical significance between the two groups. The SZL-HoL group also had better outcomes in terms of intraoperative blood loss, postoperative voice quality, duration of tracheotomy, duration of nasogastric tube placement, and length of hospital stay.
conclusionSZL-HoL is an effective and safe surgical approach for the treatment of T1b-T2 and selected T3 glottic cancer, offering favorable functional outcomes with acceptable oncological safety in appropriately selected patients.
Indexed as
Identifiers
42749788What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.